Bringing medical devices and drugs from R&D labs to patients demands precision at every step. Accuracy in language is crucial to guarantee that scientific data, regulatory submissions and clinical documentation are correctly conveyed. A single misstep can lead to costly delays, regulatory setbacks and safety risks. Regulus Pharma Services is a trusted partner for pharmaceutical companies, biotech innovators and medical device manufacturers seeking precise, reliable translation services for global regulatory processes. From investigational drug brochures, clinical trial protocols and standard technical documents to package inserts, inquiries and biotechnology documents, Regulus Pharma ensures that complex science is translated into clear, compliant communication. In an industry where every word can make or break a breakthrough, Regulus Pharma is the silent force helping innovation reach the world. “Our mission has always been to provide consistent, best-quality translation services to help our clients seamlessly navigate the development and regulatory processes,” says Katsuo Hoshi, representative director. Regulus Pharma began as a general technical translation agency, assisting industries with translating export manuals and consumer product documentation. Later, a pivotal partnership with a bilingual Japanese-American physician shifted the organization’s focus to the medical, pharmaceutical and biotechnology sectors. Over the years, Regulus Pharma has evolved alongside industry demands. Today, it focuses on regulatory science, providing translation services at every stage of drug and medical device development. These include preclinical studies, clinical trials, new drug applications, consultations with regulatory authorities and post-approval activities, and post-marketing surveillance. Minimizing Errors, Maximizing Consistency A key element of Regulus Pharma’s strength is its carefully curated network of expert translators. Each translator brings extensive experience in medical and pharmaceutical translation, and many hold advanced academic degrees, including Ph.Ds in medical science..

M Regenerative Clinic has perfected the balance between cutting-edge innovation and individualized care to deliver regenerative treatments with exceptional speed. With an on-site laboratory directly integrated with its treatment areas, M Regenerative Clinic’s setup allows immediate processing of harvested stem cells. This integration minimizes the time between cell extraction and treatment application, which is critical for preserving cell viability and enhancing therapeutic potential. The clinic’s physicians can adjust the specifics of the therapy based on the patient's health condition and needs. This approach provides personalized medical care that is both effective and responsive to each patient’s unique health circumstances. The clinic ensures every treatment offered is at the pinnacle of current scientific knowledge. Partnering with the Institute of Medical Sciences at the University of Tokyo (IMS), it actively engages in cutting-edge research on stem cells, exosomes and induced pluripotent stem (iPS) cells. “Such alliances empower our clinic with a robust, evidence-based approach, allowing us to provide patients with advanced and effective therapeutic options that extend beyond mere symptomatic relief,” says Dr. Midori Meshitsuka, director..